Cong-JD(S) won by distributing liquor and money: BSY over BJP’s bypoll debacle

Udupi, Feb 27: Silver ornaments worth Rs 10 lakh were stolen from the Badakere Laxmi Janardhana temple under Byndoor police station limits in Udupi district. 

The theft which reportedly took place on Wednesday late night, came to light today morning.

Notably, this is the fourth incident reported during the last two months.

Bengaluru, Feb 28: BS Yediyurappa’s contribution to the economy is substantial, and he is one CM who has contributed largely to making India the fifth largest economy, said Defence Minister Rajnath Singh on Thursday.

“He will ensure that Karnataka contributes towards making India the third-largest economy in the coming days,” Singh said, who had flown from New Delhi to participate in the CM’s birthday celebrations.

Singh recalled Yediyurappa asking him how to increase welfare measures for farmers, and had suggested that the CM reduce interest rates on loans to help the community. “Yediyurappa took the suggestion seriously and reduced interest of loans to a mere 4 % and gradually reduced it to 1 % before coming down to zero,” Singh said, appreciating Yediyurappa’s love for farmers.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.